Trial intelligence / Profile preview

AiYu capsule plus chemotherapy for malignant lymphoma

ChiCTR-IPR-15006190Phase 4Not yet recruiting

Sponsor
Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
Start
May 2015
Countries
1
01

Overview

Phase 4 trial of AiYu capsule in lymphosarcoma and B-cell non-Hodgkin lymphoma (B-NHL) (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoints: Type-B ultrasonic assessment, Computed tomography assessment and 1 more. Planned start May 2015; status: not yet recruiting.

02

Drugs

AiYu capsule
03

Conditions

lymphosarcomaB-cell non-Hodgkin lymphoma (B-NHL)

Beyond the preview

Go deeper on ChiCTR-IPR-15006190.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-15006190.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call